Related Experiment Videos
Metabolite analysis in positron emission tomography studies: examples from food sciences
1Positron Emission Tomography Center, Institute of Bioinorganic and Radiopharmaceutical Chemistry, Research Center Rossendorf, Dresden, Germany. b.pawelke@fz-rossendorf.de
Amino Acids
|June 1, 2005
Summary
Metabolite analysis is crucial for accurate positron emission tomography (PET) imaging. This study details methods for analyzing radiolabeled tracers, essential for quantitative PET and understanding metabolic pathways in food science.
Area of Science:
- Radiochemistry and Nuclear Medicine
- Analytical Chemistry
- Food Science and Technology
Background:
- Positron emission tomography (PET) uses radiolabeled tracers to quantify tissue function.
- Quantitative PET analysis requires understanding the metabolic fate of these tracers.
- Metabolite analysis is essential for accurate interpretation of PET imaging and identifying metabolic pathway alterations.
Purpose of the Study:
- To highlight the importance of metabolite analysis for quantitative PET.
- To present representative radiolabeled compounds relevant to food science.
- To describe analytical methods and challenges for metabolite profiling.
Main Methods:
- Dynamic data acquisition protocols for PET imaging.
- Radio-High-Performance Liquid Chromatography (radio-HPLC) and Radio-Thin-Layer Chromatography (radio-TLC) for metabolite separation.
- Pre-analytical sample preparation for plasma, urine, and tissue.
Main Results:
- Demonstrated the application of radio-HPLC and radio-TLC for analyzing radiolabeled tracers.
- Presented results from plasma, urine, and tissue sample analyses.
- Discussed the metabolic fate of various tracers, including amino acids, polyphenols, and AGEs model compounds.
Conclusions:
- Metabolite analysis is indispensable for accurate quantitative PET imaging.
- The described methods are applicable to a range of radiolabeled compounds relevant to food science.
- Understanding tracer metabolism aids in image interpretation and pathological pathway identification.